Avenda Health AI Prostate Cancer Planning Software vs Viewer+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Avenda Health AI Prostate Cancer Planning Software
by Avenda Health
VS
Viewer+
by Lumea

AI Verdict

Avenda Health's Unfold AI is specifically designed for prostate cancer treatment planning, generating 3D maps from various patient data to aid in surgical and therapeutic decisions. Lumea's Viewer+ is a broader digital pathology viewer with AI-driven workflows for primary diagnosis across multiple specialties, focusing on efficient slide review and case management. While both leverage AI for clinical decision support and have FDA clearance, their primary applications and target users differ significantly, with Avenda Health being highly specialized in oncology treatment planning and Lumea providing a more general diagnostic pathology platform.

Choose Avenda Health AI Prostate Cancer Planning Software if…

Choose Avenda Health AI Prostate Cancer Planning Software if you are a urologist, oncologist, or radiologist seeking to precisely map prostate cancer in 3D for personalized treatment planning. This tool is ideal for guiding decisions across the entire prostate cancer care continuum, including active surveillance, focal therapy, prostatectomy, and radiation therapy, by providing a detailed visualization of tumor extent and location.

View Avenda Health AI Prostate Cancer Planning Software →

Choose Viewer+ if…

Choose Lumea's Viewer+ if you are a pathologist looking for an FDA-cleared digital pathology viewer with AI-driven workflows for primary diagnosis in a clinical setting. This tool is best suited for managing high volumes of cases, enabling rapid slide rendering, facilitating real-time comparison of multiple sections, and integrating AI tools and ancillary test ordering within a unified diagnostic suite.

View Viewer+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Avenda Health AI Prostate Cancer Planning Software Viewer+
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based platform Cloud-based or on-premise
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize features that contribute to usability. Avenda Health's Unfold AI focuses on creating intuitive 3D cancer maps and integrating with existing systems, while Lumea's Viewer+ highlights lightning-fast rendering, customizable dashboards, and integrated diagnostic tools. Without direct user feedback or comparative demonstrations, it's difficult to definitively declare a winner in usability.

Clinical Value

Avenda Health AI Prostate Cancer Planning Software

Avenda Health's Unfold AI offers a more direct and quantifiable clinical value by improving the identification of tumor extent by 71% with over 98% sensitivity in studies, and predicting extracapsular extension (ECE) risk. This directly aids in more precise treatment planning for prostate cancer. While Viewer+ is FDA-cleared for primary diagnosis and offers AI-driven workflows, its specific clinical impact metrics are not detailed in the provided information.

Pricing & Value

Tie

Both tools require contacting the company for pricing, making a direct comparison of cost-effectiveness impossible. Avenda Health does mention a new Category III CPT code for reimbursement, which could potentially improve its value proposition for providers in the future. However, without concrete pricing for either, it's a tie.

Enterprise Readiness

Viewer+

Lumea's Viewer+ offers both cloud-based and on-premise deployment options, providing greater flexibility for enterprise integration based on their IT infrastructure and security preferences. Avenda Health's Unfold AI is solely cloud-based, which might be a limitation for some organizations with strict on-premise requirements.

Innovation

Avenda Health AI Prostate Cancer Planning Software

Avenda Health's Unfold AI demonstrates a higher degree of specialized innovation by generating precise 3D cancer estimation maps from multi-modal patient data (MRI, biopsy, pathology, PSA) to specifically aid in prostate cancer treatment planning. While Viewer+ offers AI-driven workflows and an open AI marketplace, the 3D mapping and predictive analytics for a specific cancer type represent a more novel application of AI in clinical decision support.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details regarding the level of support or documentation available for either Avenda Health's Unfold AI or Lumea's Viewer+. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Avenda Health AI Prostate Cancer Planning Software Viewer+
Product Name Avenda Health AI Prostate Cancer Planning Software (Unfold AI) Lumea Viewer+
Description FDA-cleared, AI-based decision support software that creates 3D cancer maps from patient data to precisely visualize prostate cancer extent, aiding physicians in treatment planning and decision-making for personalized care. FDA-cleared digital pathology viewer with AI-driven workflows for primary diagnosis in clinical settings, supporting various specialties.
Company Avenda Health Lumea
Specialties Oncology, Radiology, Urology Pathology (specifically serves urology, dermatopathology, and gastroenterology, with applicability across virtually all surgical pathology specialties)
Key Features AI-based decision support for prostate cancer planning; Generates 3D Cancer Estimation Maps (CEM) from MRI, biopsy, pathology, and PSA data; Precisely maps prostate cancer location and extent in 3D; Aids in surgical planning and treatment decision-making (active surveillance, prostatectomy, radiation, focal therapy); Improves identification of tumor extent (71% improvement, over 98% sensitivity in studies); Supports segmentation of MR image features and lesion documentation; Data exportable to compatible interventional or biopsy systems; Predicts extracapsular extension (ECE) risk. FDA-cleared for primary diagnosis in clinical settings; AI-driven workflows and open AI marketplace integration; Lightning-fast, full slide rendering; DxAlign for real-time comparison of multiple sections and stains; Customizable dashboards for personalized workflow; Comprehensive case management (slide orders, gross images, patient history); Integrated diagnostic tools on a single screen; Instant second opinions and enhanced collaboration.

Videos

Demos, reviews, and walkthroughs featuring Avenda Health AI Prostate Cancer Planning Software and Viewer+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Avenda Health AI's Unfold AI generates 3D cancer maps and aids in treatment planning, with data exportable to compatible interventional or biopsy systems, suggesting integration points for treatment execution. Lumea's Viewer+ offers comprehensive case management, including slide orders, gross images, and patient history, implying deeper integration with patient data within the diagnostic workflow.
Avenda Health AI's Unfold AI demonstrates significant accuracy improvements, with a 71% improvement in identifying tumor extent and over 98% sensitivity in studies for prostate cancer mapping. Lumea's Viewer+ is FDA-cleared for primary diagnosis and features AI-driven workflows, but specific accuracy or sensitivity metrics for its AI are not detailed in the provided information.
Avenda Health AI's Unfold AI is highly specialized for prostate cancer planning, directly supporting oncologists and urologists with precise 3D cancer maps for treatment decisions. Lumea's Viewer+ is designed for digital pathology, offering AI-driven workflows and comprehensive case management that directly enhances the primary diagnostic workflow for pathologists.
Avenda Health AI's Unfold AI generates visual 3D cancer maps from existing patient data, which may have a moderate learning curve for interpreting and integrating these new visual aids into established treatment planning. Lumea's Viewer+ offers customizable dashboards and integrated diagnostic tools, suggesting an intuitive interface, but adapting to new AI-driven pathology workflows may still require dedicated training.
Avenda Health AI's Unfold AI aids in treatment decision-making and planning, implying that the generated 3D maps and associated data could form part of a patient's record for audit purposes, though specific audit-trail features are not detailed. Lumea's Viewer+ offers comprehensive case management and integrated diagnostic tools, which would inherently support an audit trail of diagnostic activities, but explicit audit-trail features are not specified.
Avenda Health AI's Unfold AI, being a cloud-based platform that generates standardized 3D cancer maps, could facilitate consistent prostate cancer planning across multiple sites. Lumea's Viewer+, with its cloud-based or on-premise deployment and standardized AI-driven workflows, is well-suited for multi-site implementation to standardize digital pathology diagnostics.
The provided information does not detail specific security measures beyond HIPAA compliance for either Avenda Health AI's Unfold AI or Lumea's Viewer+. Both are cloud-based (with Lumea also offering on-premise), suggesting standard cloud security protocols would be in place, but no additional specific measures are mentioned.

More Comparisons

Heidi Health vs Wysa
When choosing between Heidi Health and Wysa, physicians should consider their primary need: clinical documentation automation versus AI-driven mental health…
BriefCase vs Oracle Health AI-backed EHR
When choosing between Aidoc's BriefCase and Oracle Health AI-backed EHR, physicians should consider their primary need: enhanced communication for critical…
Butterfly iQ/iQ+ Ultrasound System vs Radium
For physicians evaluating AI tools, the Butterfly iQ/iQ+ Ultrasound System and Radium offer distinct functionalities tailored to different clinical needs.…
Butterfly iQ/iQ+ Ultrasound System vs RAYUS Radiology (formerly Insight Health)

More matchups featuring Avenda Health AI Prostate Cancer Planning Software or Viewer+

Backers

Who funded each tool's parent company.

Avenda Health AI Prostate Cancer Planning Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.